TLOG (TetraLogic Pharmaceuticals) Total Stockholders Equity: $-30.94 Mil (As of Sep. 2016)


What is TetraLogic Pharmaceuticals Total Stockholders Equity?

TetraLogic Pharmaceuticals TLOG Total Stockholders Equity is $-30.94 Mil as of Sep. 2016.

TetraLogic Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2016 was $-30.94 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. TetraLogic Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2016 was $-1.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. TetraLogic Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2016 was -1.00.

TetraLogic Pharmaceuticals  (OTCPK:TLOG) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

TetraLogic Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2016 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-30.938-0)/24.769
=-1.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

TetraLogic Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2016 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 30.809) / -30.938
=-1.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Total Stockholders Equity Related Terms

TetraLogic Pharmaceuticals Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Total Stockholders Equity Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Total Stockholders Equity
-52.59 -68.44 50.55 33.40 -5.94

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 -5.94 -16.06 -22.26 -30.94
What does a Total Stockholders Equity of $-30.94 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Total Stockholders Equity of $-30.94 Mil as of Sep. 2016. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Total Stockholders Equity too high?
TetraLogic Pharmaceuticals' current Total Stockholders Equity is $-30.94 Mil.
How does TetraLogic Pharmaceuticals' Total Stockholders Equity compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Total Stockholders Equity of $-30.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Total Stockholders Equity is $-30.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Total Stockholders Equity of $-30.94 Mil. The current Total Stockholders Equity is $-30.94 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Total Stockholders Equity is $-30.94 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.